Clinicians are well aware of long COVID, the enduring health conditions caused by the SARS-CoV-2 virus’ ability to attack multiple organ systems.
Trial of Fluticasone Furoate Didn’t Show Benefits for COVID-19 Outpatients
Inhaled glucocorticoids do not appear to be effective in shortening the time to symptom resolution or preventing hospitalization or death among outpatients with mild-to-moderate COVID-19, according to a recent study.
No Excess Late Mortality for Veterans Who Survived COVID-19
The devastating toll of acute COVID-19 infections on human lives is well documented. Yet a pressing question remains: Do survivors of acute COVID-19 face a higher risk of mortality in the aftermath of their infection and, if so, for how long does this risk persist?
Tixagevimab/Cilgavimab Found Effective in Immunocompromised Veterans
The risk of COVID-19 morbidity and mortality is much higher for immunocompromised patients, and, while vaccines have been highly successful at preventing the spread of SARS-CoV-2 and decreasing the likelihood of severe disease in the general population, those who are immunocompromised still face a greater danger for breakthrough infections and persistent viral replication, according to a new study.
Veterans Who Got COVID Shots More Likely to Accept Flu Vaccine
A new VA study sought to determine whether acceptance of the COVID-19 vaccine might have influenced update of annual influenza vaccination.
Racial Disparity Common in Receipt of High-Dose Influenza Vaccines
Racial disparities in receipt of high-dose influenza vaccine (HDV) have been documented nationally, but a new study sought to determine if small-area geographic variation in such disparities also exists.
Comparison of the Adjuvanted, High-Dose Influenza Vaccines for Older Adults
Which provides better protection for older adults: the adjuvanted inactivated influenza vaccine (aIIV) or high-dose inactivated influenza vaccine (HD-IIV)?
Highly Rural Areas Appear to Have Lower Uptake of COVID-19 Vaccines
Public health officials can better target their message if they better understand where COVID-19 primary and booster vaccine uptake is low. A new VA study suggests that whether the potential recipient lives in a rural or urban area can be an important factor.
New York’s Operation COVID-19 Is Largest Domestic Mobilization in US History
On March 7, 2020, then-Gov. Andrew Cuomo signed Executive Order 202 declaring a state of emergency for the state of New York. Within days, military forces in the state mobilized to respond to the pandemic with the deployment of 270 servicemembers from the New York Army National Guard and Air National Guard to New Rochelle in Westchester County
VA Faces Challenges in Diagnosing, Caring for Long COVID
In the early days and months of the COVID-19 pandemic, the VA and other healthcare systems were focused on the daunting work of helping patients survive the acute effects of the disease.
Vaccinations Can Help Prevent Flu, COVID-19 Co-Infection
While co-infection with more than one respiratory virus was especially a problem this fall and winter, it has happened before, especially in an environment where SARS-CoV-2 is circulating.
Study Examines Reasons for Vaccine Hesitancy in Patients With IBD
Even after years of the COVID-19 pandemic, data remains somewhat limited on the safety profile of SARS-CoV-2 vaccine in patients taking immunosuppressive medications.
Severe COVID-19 Illness Low for Veterans After Vaccination Plus Booster
Veteran patients who received a COVID-19 vaccination series, plus a booster vaccine dose, had a low incidence of hospitalization, death or severe illness from COVID-19, according to a new study.
Race Appeared to be Factor in Treatment of Veterans Hospitalized With COVID-19
Black veteran patients received different medical interventions than white patients when hospitalized with COVID-19 in VAMCs across the country, according to a new study.
Blood Sugars Higher for Flu Vaccine Recipients With Diabetes
The Vaccine Adverse Effect Reporting System, established by the national Centers for Disease Control and Prevention, has more than 350 reports of hyperglycemia post-influenza vaccine, according to a new study.
Elderly Veterans More Likely to Die from COVID-19 Than Flu
An often repeated misconception during the COVID-19 pandemic is that the Sars-C0V-2 and influenza viruses are similarly fatal for older adults, although there have been limited data to support that observation.
Yellow Fever Vaccine Response Lower After Flu Vaccine
The DoD’s support of the United States government’s response to the Ebola crisis in Liberia, beginning in 2014‐2015, was the first U.S. military operation to support a disease‐driven foreign humanitarian assistance mission.
Despite Allergic-Type Reactions, Military Study Found Many Patients Can Tolerate Second Dose of COVID-19 mRNA Vaccine
Although serious allergic reactions to mRNA vaccines are extremely rare, fear of them has driven hesitancy among some potential recipients. That especially has been the case when an adverse effect occurred after the first dose.
Low VHA COVID-19 Booster Rates Leave Veterans Vulnerable to Severe Cases
President Joe Biden, despite being 79 years old, had a mild case of COVID-19. The primary explanation for why he escaped severe symptoms is that he was not only vaccinated, but double-boosted.
Million Veteran Program Helps Link Genes for Severe COVID-19, Other Diseases
From the earliest days of the pandemic, it was evident that people with certain medical conditions faced an increased risk of severe COVID-19.
‘Pan-Coronavirus’ Vaccine Developed by Army Research Shows Promise
Based on recent preclinical study results, the Spike Ferritin Nanoparticle (SpFN) COVID-19 vaccine is showing significant promise.
VA Studies Continue to Demonstrate High COVID-19 Vaccine Effectiveness
From the time the COVID-19 mRNA vaccines became available in late 2020, VA studies have been crucial to understanding their effectiveness in real life.
How Deployed Military Personnel Viewed COVID-19 Vaccination
To better understand vaccine hesitancy related to COVID-19 shots, a study recently looked at how likely deployed military personnel is to be vaccinated.
Moderna COVID-19 Vaccine Proves More Effective Than Similar Pfizer Product
While both of the messenger RNA vaccines used in the United States work very well, a new VA study found that, in a head-to-head comparison, the Moderna product is more effective than the Pfizer-BioNTech product.
VA Seeks to Change Initial Concerns About COVID-19 Vaccines Into Acceptance
Early in 2021, more than one-fourth of veterans responding to a survey said they were concerned about getting a COVID-19 vaccine. The VA has worked steadily since then to change their minds.
Which Cancer Patients Get Most Protection From COVID-19 Vaccines?
With new variants popping up and steady occurrence of breakthrough infections, the question of the effectiveness of SARS-CoV-2 vaccination in patients with cancer has not really been answered until now.
VA Played Critical Role in Successful Roll-Out of COVID-19 Vaccines
When the COVID-19 vaccines rolled out last winter, a unique partnership between the VHA and other federal agencies provided the first real-world evidence—outside of clinical trials—of how well the vaccines were working.
Death Rate Increases for VA Patients Lagged Community Levels Last Year
Despite older age and more potentially dangerous comorbidities, veterans receiving VA care fared better last year than those treated in community healthcare systems during the COVID-19 pandemic, according to a new study.
As Deadlines Neared, DoD Moves Toward Fully Vaccinating Active-Duty Troops
The DoD is moving steadily toward its goal of vaccinating all military personnel. By early November, 97% of the DoD’s active-duty force had received at least one dose of COVID-19 vaccine.
Only About Half of ASCVD Patients Get Influenza Vaccines
Only about half of U.S. patients with atherosclerotic cardiovascular disease receive annual influenza vaccine, and the rate is lower among Black and Hispanic patients than white ones.